Fenwick & West represented OrsoBio in the transaction. OrsoBio,Inc. a clinical-stage biopharmaceutical company developing treatments for obesity and obesity-associated disorders, announced raising its $67 million Series...
OrsoBio’s $67 Million Series B Funding Round
OrsoBio’s $60 Million Series A Financing Round
Fenwick & West represented OrsoBio in the transaction. OrsoBio, Inc. announced its $60 million Series A financing, bringing the total capital raised by the Company to $97 million....